GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (XBRU:OXUR) » Definitions » Other Financing

Oxurion NV (XBRU:OXUR) Other Financing : €-0.38 Mil (TTM As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Oxurion NV Other Financing?

Oxurion NV's Other Financing for the six months ended in Jun. 2024 was €-0.31 Mil.

Oxurion NV's Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.38 Mil.


Oxurion NV Other Financing Historical Data

The historical data trend for Oxurion NV's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Other Financing Chart

Oxurion NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.03 -0.12 -0.66 -0.32

Oxurion NV Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 -0.44 -0.25 -0.07 -0.31

Oxurion NV Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxurion NV Other Financing Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxurion NV Business Description

Traded in Other Exchanges
Address
Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group's research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.

Oxurion NV Headlines

No Headlines